GLP-1s and skeletal muscle loss

While GLP-1 receptor agonists (RAs) have transformed the management of Type 2 diabetes and obesity, concerns remain regarding their effects on skeletal muscle, particularly the reduction in lean body mass observed during therapy. Weight loss is typically accompanied by reductions in both fat and muscle mass. Although accumulating evidence suggests that GLP-1 RAs lead to […]

Popular weight loss and diabetes drugs reduces depression, anxiety, and addiction risk

knowridge.com - 28/Mar 10:34

A new international study has found that medications used to treat diabetes and obesity may also help improve mental health. The research focused on a...

What exactly are GLP-1 medications and how do they work?

wn.com - 30/Mar 20:09

Are you thinking about starting a GLP-1 medication? About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart disease, or lose weight....

GLP-1 Receptor Agonists May Lower Risk for Worsening Mental Illness

drugs.com - 25/Mar 15:45

WEDNESDAY, March 25, 2026 -- Glucagon-like peptide-1 (GLP-1) receptor agonists, especially semaglutide, are associated with a reduced risk for...

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

wn.com - 24/Mar 16:59

The results suggest that the five-year risk of major cardiovascular events such as heart attacks and the risk of end-stage kidney disease were reduced...

Major Cardiovascular Event Risk Increased With Discontinuation of GLP-1 RAs in T2D

drugs.com - 31/Mar 16:03

TUESDAY, March 31, 2026 -- For adults with type 2 diabetes, discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated...

Major Cardiovascular Event Risk Increased With Discontinuation of GLP-1 RAs in T2D

drugs.com - 31/Mar 16:03

TUESDAY, March 31, 2026 -- For adults with type 2 diabetes, discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated...

Taking A GLP-1? Doctors Say Not To Forget About Movement And Mental Health – Analysis

eurasiareview.com - 30/Mar 00:08

By Emily Siner, Cara Anthony, Blake Farmer and Nashville Public Radio Severe ankle pain drove Jelon Smart to start taking a weight loss injection...

GLP-1 Therapies Are Shifting Obesity Care Beyond Just Weight Loss, Here's What Experts Say

wn.com - 29/Mar 12:42

GLP-1 therapies are transforming obesity treatment in India, offering benefits beyond weight loss for heart, liver, and kidney health. ......

Should you microdose Ozempic? Experts are split on risks vs benefits

wn.com - 01/Apr 19:08

The rise of GLP-1s (glucagon-like peptide-1 receptor agonists) has introduced new...

Should you microdose Ozempic? Experts are split on risks vs benefits

wn.com - 01/Apr 19:08

The rise of GLP-1s (glucagon-like peptide-1 receptor agonists) has introduced new...

Rubriques :

GLP-1s and skeletal muscle loss

Articles similaires

Popular weight loss and diabetes drugs reduces depression, anxiety, and addiction risk

What exactly are GLP-1 medications and how do they work?

GLP-1 Receptor Agonists May Lower Risk for Worsening Mental Illness

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

Major Cardiovascular Event Risk Increased With Discontinuation of GLP-1 RAs in T2D

Major Cardiovascular Event Risk Increased With Discontinuation of GLP-1 RAs in T2D

Taking A GLP-1? Doctors Say Not To Forget About Movement And Mental Health – Analysis

GLP-1 Therapies Are Shifting Obesity Care Beyond Just Weight Loss, Here's What Experts Say

Should you microdose Ozempic? Experts are split on risks vs benefits

Should you microdose Ozempic? Experts are split on risks vs benefits

Les derniers communiqués